Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Increased Mitochondrial Genetic Diversity in Persons Infected With Hepatitis C Virus.

Campo DS, Roh HJ, Pearlman BL, Fierer DS, Ramachandran S, Vaughan G, Hinds A, Dimitrova Z, Skums P, Khudyakov Y.

Cell Mol Gastroenterol Hepatol. 2016 May 26;2(5):676-684. doi: 10.1016/j.jcmgh.2016.05.012. eCollection 2016 Sep.

2.

Hepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytes.

Casciano JC, Duchemin NJ, Lamontagne RJ, Steel LF, Bouchard MJ.

PLoS One. 2017 Feb 2;12(2):e0168328. doi: 10.1371/journal.pone.0168328. eCollection 2017.

3.

MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis.

Tian T, Wang M, Zhu W, Dai ZM, Lin S, Yang PT, Liu XH, Liu K, Zhu YY, Zheng Y, Liu M, Dai ZJ.

Aging (Albany NY). 2017 Jan 31;9(2):381-392. doi: 10.18632/aging.101160.

4.

Interaction of cyclophilin A with a novel binding protein, SR-25, and characterization of their expression pattern in Chinese hepatocellular carcinoma patients.

Chen J, Li N, Lian P, Wang J, Li P, Gong Z, Jiang L.

Oncol Lett. 2016 Dec;12(6):5254-5260. doi: 10.3892/ol.2016.5357. Epub 2016 Nov 7.

5.

Hepatitis B virus molecular biology and pathogenesis.

Lamontagne RJ, Bagga S, Bouchard MJ.

Hepatoma Res. 2016;2:163-186. doi: 10.20517/2394-5079.2016.05. Epub 2016 Jul 1.

6.

Genetic polymorphisms -137 (rs187238) and -607 (rs1946518) in the interleukin-18 promoter may not be associated with development of hepatocellular carcinoma.

Zhu SL, Zhao Y, Hu XY, Luo T, Chen ZS, Zhang Y, Yang SH, Zhou L, Li LQ.

Sci Rep. 2016 Dec 21;6:39404. doi: 10.1038/srep39404.

7.

Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells.

Okagawa Y, Takada K, Arihara Y, Kikuchi S, Osuga T, Nakamura H, Kamihara Y, Hayasaka N, Usami M, Murase K, Miyanishi K, Kobune M, Kato J.

PLoS One. 2016 Dec 15;11(12):e0168355. doi: 10.1371/journal.pone.0168355. eCollection 2016.

8.

Genetic susceptibility of eight nonsynonymous polymorphisms in HLA-DRB1 gene to hepatocellular carcinoma in Han Chinese.

Shi Y, Zhai W, Wang B, Zhao D, Jin H, Wang Y, Zhang J, An H, Fu Z, Zhao K, Lu C.

Oncotarget. 2016 Dec 6;7(49):80935-80942. doi: 10.18632/oncotarget.13111.

9.

Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma.

Zhang Y, Zhu SL, Chen J, Li LQ.

Onco Targets Ther. 2016 May 30;9:3249-57. doi: 10.2147/OTT.S104904. eCollection 2016. Review.

10.
11.

Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells.

Montalbano R, Honrath B, Wissniowski TT, Elxnat M, Roth S, Ocker M, Quint K, Churin Y, Roederfeld M, Schroeder D, Glebe D, Roeb E, Di Fazio P.

Oncotarget. 2016 Apr 12;7(15):20312-23. doi: 10.18632/oncotarget.7950.

12.

A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.

Shi Y, Wang J, Wang Y, Wang A, Guo H, Wei F, Mehta SR, Espitia S, Smith DM, Liu L, Zhang Y, Chen D.

Cancer Lett. 2016 Feb 28;371(2):285-91. doi: 10.1016/j.canlet.2015.12.008. Epub 2015 Dec 17.

13.

Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus.

Gondar V, Molina-Jiménez F, Hishiki T, García-Buey L, Koutsoudakis G, Shimotohno K, Benedicto I, Majano PL.

J Virol. 2015 Oct;89(19):9962-73. doi: 10.1128/JVI.00577-15. Epub 2015 Jul 22.

14.

Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.

Lamontagne J, Steel LF, Bouchard MJ.

World J Gastroenterol. 2015 Jun 28;21(24):7375-99. doi: 10.3748/wjg.v21.i24.7375. Review.

15.

Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma.

Markowitz GJ, Michelotti GA, Diehl AM, Wang XF.

Sci Bull (Beijing). 2015 Apr 1;60(8):762-772.

16.

Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice.

Yamada HY, Zhang Y, Reddy A, Mohammed A, Lightfoot S, Dai W, Rao CV.

Carcinogenesis. 2015 Apr;36(4):429-40. doi: 10.1093/carcin/bgv011. Epub 2015 Mar 4.

17.

Mitochondrial dynamics and viral infections: A close nexus.

Khan M, Syed GH, Kim SJ, Siddiqui A.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt B):2822-33. doi: 10.1016/j.bbamcr.2014.12.040. Epub 2015 Jan 13. Review.

18.

The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival.

Rawat S, Bouchard MJ.

J Virol. 2015 Jan 15;89(2):999-1012. doi: 10.1128/JVI.02440-14. Epub 2014 Oct 29.

19.

Potential mechanisms of hepatitis B virus induced liver injury.

Suhail M, Abdel-Hafiz H, Ali A, Fatima K, Damanhouri GA, Azhar E, Chaudhary AG, Qadri I.

World J Gastroenterol. 2014 Sep 21;20(35):12462-72. doi: 10.3748/wjg.v20.i35.12462. Review.

20.

Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis.

Tarocchi M, Polvani S, Marroncini G, Galli A.

World J Gastroenterol. 2014 Sep 7;20(33):11630-40. doi: 10.3748/wjg.v20.i33.11630. Review.

Supplemental Content

Support Center